Author:
Cruz Jurado Josefina,Richart Aznar Paula,García Mata Jesus,Fernández Martínez Roberto,Peláez Fernández Ignacio,Sampedro Gimeno Teresa,Galve Calvo Elena,Murillo Jaso Laura,Polo Marqués Eduardo,García Palomo Andrés
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference70 articles.
1. Livestrong™: What is metastatic breast cancer? Available at http://www.livestrong.com/article/153776-what-is-metastatic-breast-cancer/ Accessed July 12, 2011.
2. National Comprehensive Cancer Network Website. Your breast cancer survival guide. Available at http://www.nccn.org/about/publications/pdf/Your_Breast_Cancer_SURVIVAL_Guide.pdf Accessed July 12, 2011.
3. Burstein HJ, Prestrud AA, Seidenfeld J. American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. J Clin Oncol. 2010;28:3784–3796.
4. Jones S, Vogel C, Arkhipov A, et al. Aromasin Study Group. Multicenter, phase II trial of exemestane as third-line hormonal therapy of postmenopausal women with metastatic breast cancer. J Clin Oncol. 1999;17:3418–3425.
5. Thürlimann B, Paridaens R, Serin D, et al. Exemestane Study Group. Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on aminoglutethimide: a phase II multicentre multinational study. Eur J Cancer. 1997;33:1767–1773.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献